Omead Ostadan
Chief Executive Officer at Cellanome, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter J. Fromen | M | 49 |
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 2 years |
| Mostafa Ronaghi | M | 55 |
Cellanome, Inc.
 Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company based in Palo Alto, CA. Cellanome, Inc. has brought together an experienced team with expertise in sequencing, microfluidics, integrated sensors, information technology, molecular biology, and biochemistry. The company is fortunate to partner with leading life science investors who share their passion and long-term vision. The company was founded by Mostafa Ronaghi and the CEO is Omead Ostadan. | 16 years |
| Charles Dadswell | M | 65 | 11 years | |
| Ali Agah | M | - |
Cellanome, Inc.
Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company based in Palo Alto, CA. Cellanome, Inc. has brought together an experienced team with expertise in sequencing, microfluidics, integrated sensors, information technology, molecular biology, and biochemistry. The company is fortunate to partner with leading life science investors who share their passion and long-term vision. The company was founded by Mostafa Ronaghi and the CEO is Omead Ostadan. | - |
| David Horn | M | 56 | 4 years | |
| Gail Marcus | M | 67 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Bobby Yerramilli-Rao | M | 58 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 12 years |
| Caroline Dorsa | F | 64 | 7 years | |
| Meeta Gulyani | F | 54 | 3 years | |
| Rachel Haurwitz | M | 37 | 3 years | |
| Shankar Balasubramanian | M | - |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 12 years |
| Elona Kogan | F | 54 | 4 years | |
| Robert Epstein | M | 58 | 12 years | |
| Frances Arnold | M | 67 | 8 years | |
| Dipchand Nishar | M | 54 | 3 years | |
| Susan Siegel | F | 63 | 5 years | |
| Scott Gottlieb | M | 51 | 4 years | |
| Martin Murphy | M | 55 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Gary Guthart | M | 58 | 7 years | |
| Philip Schiller | M | 63 | 8 years | |
| Thomas William Hulme | M | 48 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Alice Newcombe-Ellis | F | 41 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Fiona Stewart | F | - |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 4 years |
| Roelof Botha | M | 50 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 9 years |
| Tarun Kumar Khurana | M | - |
Cellanome, Inc.
Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company based in Palo Alto, CA. Cellanome, Inc. has brought together an experienced team with expertise in sequencing, microfluidics, integrated sensors, information technology, molecular biology, and biochemistry. The company is fortunate to partner with leading life science investors who share their passion and long-term vision. The company was founded by Mostafa Ronaghi and the CEO is Omead Ostadan. | - |
| Scott Ericksen | M | 52 | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Walt | M | 71 | 18 years | |
| Philip Ma | M | 59 | - | |
| John Thompson | M | 74 | 6 years | |
| Roy Whitfield | M | 70 |
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 11 years |
| William Rastetter | M | 75 | 18 years | |
| John Stuelpnagel | M | 66 | 11 years | |
| Arthur Bowman | M | 77 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 12 years |
| Francis deSouza | M | 53 | 10 years | |
| Marc Stapley | M | 54 | 7 years | |
| Robert Kelley | M | 52 | 7 years | |
| Nicholas Naclerio | M | 62 | 6 years | |
| Catherine Friedman | F | 63 | 3 years | |
| John West | M | 67 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 3 years |
| Kevin Williams | M | - | - | |
| Paul Grint | M | 66 | 8 years | |
| Michael Bouchard | M | 57 | - | |
| Joydeep Goswami | M | 52 | 5 years | |
| Daniel Bradbury | M | 62 | 13 years | |
| Kathy A. San Roman | F | 70 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 15 years |
| Karin Eastham | F | 74 | 15 years | |
| Matthew Posard | M | 56 | 9 years | |
| Gerald Heinz Möller | M | 80 | 5 years | |
| Christian G. Cabou | M | 74 | 7 years | |
| Karen Possemato | F | - | - | |
| Tony Smith | M | 68 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 2 years |
| Dalen Meeter | M | 46 | 9 years | |
| Christian Henry | M | 56 | 12 years | |
| Michele Farmer | F | - | 12 years | |
| Sanjay Chikarmane | M | - | 2 years | |
| Neil Ward | M | - | 13 years | |
| Paul L. Bianchi | M | 61 | 4 years | |
| Subra Sankar | M | 64 | 6 years | |
| Phillip Febbo | M | 57 | 5 years | |
| AmirAli Talasaz | M | 44 | 1 years | |
| Garret Hampton | M | 58 | 3 years | |
| Sam Samad | M | 54 | 5 years | |
| Paula Dowdy | F | 58 | 7 years | |
| Justin O. Emory | M | 45 | 6 years | |
| Nick Nelson | M | 41 | 10 years | |
| Shaun Holt | M | 46 | 7 years | |
| Samraat Raha | M | 52 | 4 years | |
| Wouter Meuleman | M | - | 4 years | |
| Jonathan Seaton | M | 53 | - | |
| Troy Seelye | M | 60 | 9 years | |
| Min-Jui Shen | M | 60 | 16 years | |
| Stephane Mouradian | M | - | 6 years | |
| Craig Ciesla | M | 51 | 6 years | |
| Tina Nova | M | 70 | 1 years | |
| Daniel S. Grosu | M | - | - | |
| Mark McClellan | M | 60 | - | |
| Robert Ragusa | M | 64 | 8 years | |
| Tristan B. Orpin | M | 58 | 15 years | |
| Karen McGinnis | F | 57 | 4 years | |
| Kirk Malloy | M | 57 | 14 years | |
| B. Cimler | M | 66 | - | |
| Jeffrey Hawkins | M | 46 | 3 years | |
| David Barker | M | 82 | 7 years | |
| Robert C. Kain | M | 63 | 15 years | |
| Alexander Dickinson | M | 62 | 7 years | |
| Norman Fjeldheim | M | - | - | |
| Jacquie Ross | F | - | 4 years | |
| Aimee Hoyt | F | 53 | - | |
| Juliet C. Cunningham | F | - | - | |
| Laura Lauman | F | - | - | |
| Mya Thomae | F | - | 3 years | |
| Jeffrey Huber | M | 55 | 1 years | |
| Jack Goldstein | M | 77 | 4 years | |
| Gregory F. Heath | M | 66 | - | |
| Alex Aravanis | M | 48 | 3 years | |
| Stephen Pentoney | M | - | - | |
| Jorge Velarde | M | 57 | 11 years | |
| William Bonnar | M | - | - | |
| Emily Winn-Deen | M | - | - | |
| Brandon Poe | M | - | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 92 | 92.00% |
| United Kingdom | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Omead Ostadan
- Personal Network
